Regenerative biotechnology
Gencell® Native CTM
Native mesenchymal stem cells for systemic regenerative support.
Injectable solution of native mesenchymal stem cells with immunomodulatory, regenerative, and anti-inflammatory capacity, indicated as an adjunct in chronic, autoimmune, inflammatory conditions and dermatocosmetic procedures.
Composition
Native mesenchymal stem cells.
Pharmaceutical form
Injectable solution.
Presentation
Monovette with 4 ml.
Therapeutic Properties
They promote tissue repair and regeneration through immunomodulation, secretion of bioactive factors, inhibition of apoptosis, stimulation of cellular proliferation, and directed transdifferentiation in damaged tissues.
- Modulation of the immune response.
- Reduction of chronic inflammation.
- Secretion of growth factors.
- Stimulation of angiogenesis.
- Inhibition of cellular apoptosis.
- Promotion of cellular proliferation.
- Directed tissue transdifferentiation.
- Support for regeneration of damaged tissues.
Mechanism of action & Clinical data
They migrate to the site of injury, modulate inflammation, secrete bioactive factors, inhibit apoptosis, and promote cellular proliferation and differentiation for tissue repair.
Indications
Adjunct in chronic-degenerative, autoimmune, chronic inflammatory conditions and dermatocosmetic rejuvenation procedures.
Administration
Intravenous route via slow infusion diluted in 0.9% saline solution, without bolus.
Contraindications
Hypersensitivity to formula components. Diagnosis of neoplasia.
Storage
Store refrigerated between 2 and 8 °C, protected from direct sunlight. Do not freeze.
